<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>Moreover Technologies - Biotech news - 30 of 3003 returned</title>
    <link>http://www.moreover.com/rss</link>
    <description>Moreover Technologies - Real-time news and blogs from thousands of sources</description>
    <language>en-us</language>
    <image>
      <title>Moreover Technologies</title>
      <url>http://i.moreover.com/pics/rss.gif</url>
      <link>http://www.moreover.com/rss</link>
      <width>144</width>
      <height>16</height>
      <description>Moreover Technologies - Premier purveyor of real-time news and RSS feeds from across the Web</description>
    </image>
    <item>
      <title>Refinance As Low As 5.48% - Sponsored Link</title>
      <link>/cgi-bin/rss_query_image.cgi?a=click&amp;bid_id=91274553&amp;clickid=87877635&amp;format=xml1&amp;cgroup=biotechnews&amp;query=business&amp;ts=ad20090108000000</link>
      <description>Ad - Compare Up to 4 Free Offers. Home Refinance Inquiries Only.</description>
      <guid isPermaLink="false">ad20090108000000</guid>
      <pubDate>Thu, 8 Jan 2009 05:50:00 GMT</pubDate>
    </item>
    <item>
      <title>Chiome Bioscience and Chugai Pharmaceutical Announce Research Agreement</title>
      <link>http://c.moreover.com/click/here.pl?r1760858062</link>
      <description>News source: Business Wire Chiome Bioscience and Chugai Pharmaceutical Co., Ltd. have signed a joint research agreement for the generation of monoclonal antibodies against multiple target proteins chosen by Chugai Pharmaceutical. Chiome and Chugai will</description>
      <guid>http://c.moreover.com/click/here.pl?r1760858062</guid>
      <pubDate>Thu, 8 Jan 2009 05:50:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Genetic%20Engineering%20News&amp;o=rss002">Genetic Engineering News</source>
    </item>
    <item>
      <title>MedImmune submits MAA to EMEA for intranasal vaccine to prevent flu</title>
      <link>http://c.moreover.com/click/here.pl?r1760856734</link>
      <description>MedImmune, the global biologics unit of AstraZeneca, has submitted a Marketing Authorisation Application (MAA) for its nasal spray live attenuated influenza vaccine (LAIV), which is now being reviewed by the European Medicines Agency (EMEA). The proposed</description>
      <guid>http://c.moreover.com/click/here.pl?r1760856734</guid>
      <pubDate>Thu, 8 Jan 2009 05:48:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=PharmaBiz&amp;o=rss002">PharmaBiz</source>
    </item>
    <item>
      <title>Society needs biotech innovation and so it should organize money</title>
      <link>http://c.moreover.com/click/here.pl?r1760855764</link>
      <description>Bangalore: President of the European Federation of Biotechnology Marc Van Montagu is a molecular biologist who pioneered the transgenic technology by discovering the gene transfer mechanism that made Agrobacterium tumefaciens a delivery system for making</description>
      <guid>http://c.moreover.com/click/here.pl?r1760855764</guid>
      <pubDate>Thu, 8 Jan 2009 05:47:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Livemint%2Ecom&amp;o=rss002">Livemint.com</source>
    </item>
    <item>
      <title>GM crops 'reduce toxic pesticide use'</title>
      <link>http://c.moreover.com/click/here.pl?r1760855465</link>
      <description>The NSW government says the move to genetically modified (GM) crops has greatly reduced the need for toxic pesticides such as endosulfan, which the Greens want banned. 'Endosulfan is a highly toxic pesticide,' NSW Greens MP John Kaye said on Thursday,</description>
      <guid>http://c.moreover.com/click/here.pl?r1760855465</guid>
      <pubDate>Thu, 8 Jan 2009 05:47:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=The%20Age&amp;o=rss002">The Age</source>
    </item>
    <item>
      <title>Zacks Releases Four Powerful "Buy" Stocks: Celera Corp., Harris Corp., Life Partners Holdings and CARBO Ceramics</title>
      <link>http://c.moreover.com/click/here.pl?r1760843156</link>
      <description>Extract not available.</description>
      <guid>http://c.moreover.com/click/here.pl?r1760843156</guid>
      <pubDate>Thu, 8 Jan 2009 05:34:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=TradingMarkets&amp;o=rss002">TradingMarkets</source>
    </item>
    <item>
      <title>GM crops 'reduce toxic pesticide use'</title>
      <link>http://c.moreover.com/click/here.pl?r1760839015</link>
      <description>The NSW government says the move to genetically modified (GM) crops has greatly reduced the need for toxic pesticides such as endosulfan, which the Greens want banned. 'Endosulfan is a highly toxic pesticide,' NSW Greens MP John Kaye said on Thursday,</description>
      <guid>http://c.moreover.com/click/here.pl?r1760839015</guid>
      <pubDate>Thu, 8 Jan 2009 05:30:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Sydney%20Morning%20Herald&amp;o=rss002">Sydney Morning Herald</source>
    </item>
    <item>
      <title>DuPont Applied BioSciences Recognized for Rapid Development of BioMaterials Portfolio</title>
      <link>http://c.moreover.com/click/here.pl?r1760838715</link>
      <description>- DuPont recently received the '2008 European Bioplastics Product Line Strategy Award? from Frost &amp;amp; Sullivan for its accomplishments in rapidly developing an extremely diverse range of high-performance materials based on renewable sources. Several</description>
      <guid>http://c.moreover.com/click/here.pl?r1760838715</guid>
      <pubDate>Thu, 8 Jan 2009 05:30:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Chemie%2Ede&amp;o=rss002">Chemie.de</source>
    </item>
    <item>
      <title>Crucell inks Star research &amp; license pact with Centocor for monoclonal antibodies</title>
      <link>http://c.moreover.com/click/here.pl?r1760833998</link>
      <description>Dutch biopharmaceutical company Crucell NV announced a non-exclusive Star research and commercial license agreement with Pennsylvania-based Centocor, Inc for the production of monoclonal antibodies. Financial details of the agreement were not disclosed.</description>
      <guid>http://c.moreover.com/click/here.pl?r1760833998</guid>
      <pubDate>Thu, 8 Jan 2009 05:25:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=PharmaBiz&amp;o=rss002">PharmaBiz</source>
    </item>
    <item>
      <title>Monsanto shares soar on bullish 1st Qtr results</title>
      <link>http://c.moreover.com/click/here.pl?r1760829663</link>
      <description>By Armando Duke (AXcess News) Houston - Shares of Monsanto Co. (NYSE: MON) rose more than 16.5% in midday trading in New York Wednesday after the company reported strong first quarter earnings that beat street estimates. According to the fertilizer</description>
      <guid>http://c.moreover.com/click/here.pl?r1760829663</guid>
      <pubDate>Thu, 8 Jan 2009 05:21:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=AXcess%20News&amp;o=rss002">AXcess News</source>
    </item>
    <item>
      <title>Job Loss, Big Stockpiles Kill Oil. Monsanto Jumps On Q1 Profit...</title>
      <link>http://c.moreover.com/click/here.pl?r1760827635</link>
      <description>Extract not available.</description>
      <guid>http://c.moreover.com/click/here.pl?r1760827635</guid>
      <pubDate>Thu, 8 Jan 2009 05:19:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Investors%20Business%20Daily&amp;o=rss002">Investors Business Daily</source>
    </item>
    <item>
      <title>A Flood of New Products Coming from Monsanto</title>
      <link>http://c.moreover.com/click/here.pl?r1760816916</link>
      <description> Agriculture Markets Futures MO Last Chg Corn March 416'4 -11'0 Soybeans January 990'0 -24'2 Wheat March 613'2 -30'2 Milk January 10.83 -0.16 Feeder Cattle January 94.500 -1.625 Live Cattle February 85.775 -2.775 Lean Hogs February 63.550 -0.400 Cotton</description>
      <guid>http://c.moreover.com/click/here.pl?r1760816916</guid>
      <pubDate>Thu, 8 Jan 2009 05:08:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=AgWeb%2Ecom&amp;o=rss002">AgWeb.com</source>
    </item>
    <item>
      <title>Genomics in China</title>
      <link>http://c.moreover.com/click/here.pl?r1760814642</link>
      <description>Medical Science News Ten years ago, the Chinese National Human Genome Center at Shanghai (South Center, hereafter) was established in the Zhangjiang HiTech Park of Pudong District in Shanghai. To commemorate this important event, which marks the</description>
      <guid>http://c.moreover.com/click/here.pl?r1760814642</guid>
      <pubDate>Thu, 8 Jan 2009 05:06:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=News%2DMedical%2ENet&amp;o=rss002">News-Medical.Net</source>
    </item>
    <item>
      <title>Limits of biometrics</title>
      <link>http://c.moreover.com/click/here.pl?r1760783957</link>
      <description> Bruce Schneier  GUARDIAN NEWS SERVICE  Biometrics may seem new, but they're the oldest form of identification. Tigers recognise each other's scent; penguins recognise calls. Humans recognise each other by sight from across the room, voices on the phone,</description>
      <guid>http://c.moreover.com/click/here.pl?r1760783957</guid>
      <pubDate>Thu, 8 Jan 2009 04:32:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=The%20Hindu&amp;o=rss002">The Hindu</source>
    </item>
    <item>
      <title>ALLIANCE BIOSCIENCES ANNOUNCES TRADE MISSION TO SINGAPORE WITH SPEAKER PRESENTATION AT INTERNATIONAL LAB DESIGN SEMINAR</title>
      <link>http://c.moreover.com/click/here.pl?r1760772319</link>
      <description> RICHMOND, Va., Jan. 8 /PRNewswire-AsiaNet/ --- Dr. Ryan Burnette, Director Of Alliance Biosciences Will Lead A Trade Mission To Singapore January 19, 2009 Through January 23, 2009. Dr. Burnette Will Be Promoting The Need For International Accreditation</description>
      <guid>http://c.moreover.com/click/here.pl?r1760772319</guid>
      <pubDate>Thu, 8 Jan 2009 04:18:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Smart%20News%20Network&amp;o=rss002">Smart News Network</source>
    </item>
    <item>
      <title>Drug from genetically engineered goats a first</title>
      <link>http://c.moreover.com/click/here.pl?r1760771752</link>
      <description>You've heard of making cheese from goats' milk, but prescription drugs? In what would be a scientific first, an anti-clotting drug made from the milk of genetically engineered goats moved closer to government approval Wednesday after experts at the Food</description>
      <guid>http://c.moreover.com/click/here.pl?r1760771752</guid>
      <pubDate>Thu, 8 Jan 2009 04:18:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=San%20Francisco%20Chronicle&amp;o=rss002">San Francisco Chronicle</source>
    </item>
    <item>
      <title>FDA Draft Guidance on Potency Tests for Cellular and Gene Therapy Products</title>
      <link>http://c.moreover.com/click/here.pl?r1760765473</link>
      <description>Extract not available.</description>
      <guid>http://c.moreover.com/click/here.pl?r1760765473</guid>
      <pubDate>Thu, 8 Jan 2009 04:12:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=BIO&amp;o=rss002">BIO</source>
    </item>
    <item>
      <title>Chiome Bioscience and Chugai Pharmaceutical Announce Research Agreement</title>
      <link>http://c.moreover.com/click/here.pl?r1760740186</link>
      <description>TOKYO - (Business Wire) Chiome Bioscience and Chugai Pharmaceutical Co., Ltd. have signed a joint research agreement for the generation of monoclonal antibodies against multiple target proteins chosen by Chugai Pharmaceutical. Chiome and Chugai will</description>
      <guid>http://c.moreover.com/click/here.pl?r1760740186</guid>
      <pubDate>Thu, 8 Jan 2009 03:49:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Earthtimes%2Eorg&amp;o=rss002">Earthtimes.org</source>
    </item>
    <item>
      <title>Latin American Seeds Bloom For Monsanto</title>
      <link>http://c.moreover.com/click/here.pl?r1760738090</link>
      <description>First-quarter profit more than doubles on strong demand south of the border. Monsanto can thank its friends south of the border for helping to double the agricultural chemical company?s fiscal first-quarter profit. Greater demand in Latin America</description>
      <guid>http://c.moreover.com/click/here.pl?r1760738090</guid>
      <pubDate>Thu, 8 Jan 2009 03:47:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Forbes%2Ecom&amp;o=rss002">Forbes.com</source>
    </item>
    <item>
      <title>Cell Biosciences Delivers Next Generation System to Stanford University</title>
      <link>http://c.moreover.com/click/here.pl?r1760705357</link>
      <description> PALO ALTO, Calif., Jan. 6 /PRNewswire/ -- Cell Biosciences, Inc., a provider of nanoproteomic analysis systems to life science researchers, today announced the placement of a next-generation protein analysis system prototype, the Cell Biosciences</description>
      <guid>http://c.moreover.com/click/here.pl?r1760705357</guid>
      <pubDate>Thu, 8 Jan 2009 03:20:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Pharma%20Live&amp;o=rss002">Pharma Live</source>
    </item>
    <item>
      <title>Crucell Announces Star Research and Commercial License Agreement with Centocor, Inc.</title>
      <link>http://c.moreover.com/click/here.pl?r1760705277</link>
      <description> - Dutch biopharmaceutical company Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) today announced a non-exclusive STAR research and commercial license agreement with Pennsylvania-based Centocor, Inc. for the production of monoclonal</description>
      <guid>http://c.moreover.com/click/here.pl?r1760705277</guid>
      <pubDate>Thu, 8 Jan 2009 03:20:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Pharma%20Live&amp;o=rss002">Pharma Live</source>
    </item>
    <item>
      <title>Teachers fear battleground over pupils biometric data</title>
      <link>http://c.moreover.com/click/here.pl?r1760698222</link>
      <description>Teachers have warned that the growing use of biometric technologies such as fingerprinting will make schools an 'ideological battleground' on issues of civil liberties and privacy. The warning from the Educational Institute of Scotland (EIS) is one of</description>
      <guid>http://c.moreover.com/click/here.pl?r1760698222</guid>
      <pubDate>Thu, 8 Jan 2009 03:13:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Glasgow%20Herald&amp;o=rss002">Glasgow Herald</source>
    </item>
    <item>
      <title>Monsanto Moves Closer to Launch of First Drought-Tolerant Corn Product</title>
      <link>http://c.moreover.com/click/here.pl?r1760688565</link>
      <description>Monsanto Company?s first-generation drought-tolerant corn product has moved to the fourth and final phase of development before an anticipated market launch early in the next decade, according to Monsanto?s annual update of its Research and</description>
      <guid>http://c.moreover.com/click/here.pl?r1760688565</guid>
      <pubDate>Thu, 8 Jan 2009 03:05:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Green%20Car%20Congress&amp;o=rss002">Green Car Congress</source>
    </item>
    <item>
      <title>Facet Biotechnology to cut 78 workers</title>
      <link>http://c.moreover.com/click/here.pl?r1760683712</link>
      <description>San Francisco Business Journal</description>
      <guid>http://c.moreover.com/click/here.pl?r1760683712</guid>
      <pubDate>Thu, 8 Jan 2009 03:01:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Biz%20Journals&amp;o=rss002">Biz Journals</source>
    </item>
    <item>
      <title>Abbott completes acquisition of Ibis Biosciences</title>
      <link>http://c.moreover.com/click/here.pl?r1760664779</link>
      <description>Abbott has completed the purchase of Ibis Biosciences, a subsidiary of Isis Pharmaceuticals, for a closing purchase price of $175 million. In addition to the closing purchase price, Isis will receive earn out payments from Abbott tied to post-closing</description>
      <guid>http://c.moreover.com/click/here.pl?r1760664779</guid>
      <pubDate>Thu, 8 Jan 2009 02:41:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Datamonitor&amp;o=rss002">Datamonitor</source>
    </item>
    <item>
      <title>MedImmune files MAA for intranasal influenza vaccine in EU</title>
      <link>http://c.moreover.com/click/here.pl?r1760664131</link>
      <description>MedImmune, the global biologics unit of AstraZeneca, has submitted a marketing authorization application for its nasal spray live attenuated influenza vaccine, which is now being reviewed by the European Medicines Agency. The proposed indication in the</description>
      <guid>http://c.moreover.com/click/here.pl?r1760664131</guid>
      <pubDate>Thu, 8 Jan 2009 02:41:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Datamonitor&amp;o=rss002">Datamonitor</source>
    </item>
    <item>
      <title>Anti-clotting drug from genetically engineered goats a first</title>
      <link>http://c.moreover.com/click/here.pl?r1760657434</link>
      <description>WASHINGTON - You've heard of making cheese from goats' milk, but prescription drugs? In what would be a scientific first, an anti-clotting drug made from the milk of genetically engineered goats moved closer to U.S. government approval Wednesday after</description>
      <guid>http://c.moreover.com/click/here.pl?r1760657434</guid>
      <pubDate>Thu, 8 Jan 2009 02:36:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Medbroadcast&amp;o=rss002">Medbroadcast</source>
    </item>
    <item>
      <title>Teachers have warned that the growing use of biometric technologies such as fingerprinting will make schools an "ideological battleground" on issues of civil liberties and privacy.</title>
      <link>http://c.moreover.com/click/here.pl?r1760645630</link>
      <description> The warning from the Educational Institute of Scotland (EIS) is one of the responses to a Scottish Government consultation on the use of biometric technology in schools. A number of local authorities have introduced a variety of biometric techniques,</description>
      <guid>http://c.moreover.com/click/here.pl?r1760645630</guid>
      <pubDate>Thu, 8 Jan 2009 02:25:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Glasgow%20Herald&amp;o=rss002">Glasgow Herald</source>
    </item>
    <item>
      <title>Chiome Bioscience and Chugai Pharmaceutical Announce Research Agreement</title>
      <link>http://c.moreover.com/click/here.pl?r1760635882</link>
      <description>Chiome Bioscience and Chugai Pharmaceutical Co., Ltd. have signed a joint research agreement for the generation of monoclonal antibodies against multiple target proteins chosen by Chugai Pharmaceutical. Chiome and Chugai will develop novel value-added</description>
      <guid>http://c.moreover.com/click/here.pl?r1760635882</guid>
      <pubDate>Thu, 8 Jan 2009 02:17:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Genetic%20Engineering%20News&amp;o=rss002">Genetic Engineering News</source>
    </item>
    <item>
      <title>Drug from genetically engineered goats a first</title>
      <link>http://c.moreover.com/click/here.pl?r1760634983</link>
      <description>WASHINGTON_You've heard of making cheese from goats' milk, but prescription drugs? In what would be a scientific first, an anti-clotting drug made from the milk of genetically engineered goats moved closer to government approval Wednesday after experts</description>
      <guid>http://c.moreover.com/click/here.pl?r1760634983</guid>
      <pubDate>Thu, 8 Jan 2009 02:16:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Therapeutics%20Daily&amp;o=rss002">Therapeutics Daily</source>
    </item>
    <item>
      <title>Chiome Bioscience and Chugai Pharmaceutical Announce Research Agreement</title>
      <link>http://c.moreover.com/click/here.pl?r1760601305</link>
      <description>TOKYO--(BUSINESS WIRE)-- Chiome Bioscience and Chugai Pharmaceutical Co., Ltd. have signed a joint research agreement for the generation of monoclonal antibodies against multiple target proteins chosen by Chugai Pharmaceutical. Chiome and Chugai will</description>
      <guid>http://c.moreover.com/click/here.pl?r1760601305</guid>
      <pubDate>Thu, 8 Jan 2009 01:42:00 GMT</pubDate>
      <source url="http://p.moreover.com/page?s=Street%20Insider&amp;o=rss002">Street Insider</source>
    </item>
  </channel>
</rss>
 